MA. Bouraghda, W. Takdemt, Y. Bououdina, M. Bouzid
{"title":"CAD 中的阿司匹林2024 年，它还是擂台之王吗？","authors":"MA. Bouraghda, W. Takdemt, Y. Bououdina, M. Bouzid","doi":"10.36347/sjams.2024.v12i05.004","DOIUrl":null,"url":null,"abstract":"With its 3,500-year history, aspirin is one of the most widely used medicines in the world. For a very long time, its place in secondary and sometimes even primary cardiovascular prevention was indisputable. However, a growing body of clinical data is calling this dogma into question. It is therefore necessary to reassess its efficacy and, above all, its safety in certain indications, such as primary cardiovascular prevention in at-risk populations, anti-platelet monotherapy following DES implantation, and post-acute coronary syndrome.","PeriodicalId":504829,"journal":{"name":"Scholars Journal of Applied Medical Sciences","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"ASPIRIN IN CAD: Is it Still the King of the Ring in 2024?\",\"authors\":\"MA. Bouraghda, W. Takdemt, Y. Bououdina, M. Bouzid\",\"doi\":\"10.36347/sjams.2024.v12i05.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"With its 3,500-year history, aspirin is one of the most widely used medicines in the world. For a very long time, its place in secondary and sometimes even primary cardiovascular prevention was indisputable. However, a growing body of clinical data is calling this dogma into question. It is therefore necessary to reassess its efficacy and, above all, its safety in certain indications, such as primary cardiovascular prevention in at-risk populations, anti-platelet monotherapy following DES implantation, and post-acute coronary syndrome.\",\"PeriodicalId\":504829,\"journal\":{\"name\":\"Scholars Journal of Applied Medical Sciences\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Scholars Journal of Applied Medical Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36347/sjams.2024.v12i05.004\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scholars Journal of Applied Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36347/sjams.2024.v12i05.004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
阿司匹林已有 3500 年的历史，是世界上使用最广泛的药物之一。在很长一段时间里，阿司匹林在心血管二级甚至一级预防中的地位无可争议。然而，越来越多的临床数据对这一教条提出了质疑。因此，有必要重新评估其在某些适应症中的疗效，尤其是安全性，例如高危人群的心血管一级预防、植入 DES 后的抗血小板单药治疗以及急性冠脉综合征后的治疗。
ASPIRIN IN CAD: Is it Still the King of the Ring in 2024?
With its 3,500-year history, aspirin is one of the most widely used medicines in the world. For a very long time, its place in secondary and sometimes even primary cardiovascular prevention was indisputable. However, a growing body of clinical data is calling this dogma into question. It is therefore necessary to reassess its efficacy and, above all, its safety in certain indications, such as primary cardiovascular prevention in at-risk populations, anti-platelet monotherapy following DES implantation, and post-acute coronary syndrome.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
